Director of Medical Research
Luis Vitetta is Director of Medical Research at Medlab and Adjunct Professor at the University of Sydney, Sydney Medical School.
Luis's expertise includes probiotics, the human biome, nutraceuticals, nutrition, clinical trials, epidemiology', integrative and complementary medicine.
Between 2007-2013 Luis was the Director and Associate Professor of the Centre for Integrative Clinical and Molecular Medicine at The University of Queensland, School of Medicine. Luis is an Honours Graduate from Monash University (1981) in the Department of Biochemistry - Faculty of Medicine, and a PhD Graduate from the University of Melbourne Faculty of Medicine's Department of Surgery (1985) where he studied the epidemiological and aetiological factors of biliary disease. He has also studied medicine at the National University of La Plata Medical School in his native Argentina.
Luis was the chief investigator and the recipient of a National Institute of Complementary Medicine grant for the NICM Collaborative Centre for Transitional/Preclinical and Clinical Research in Nutraceuticals and Herbal Medicines.
Luis was a Senior Research Fellow at the Centre for Molecular Biology and Medicine, Epworth Medical Centre in Melbourne.
Between the years of 2000-2005 Luis was the Deputy Head and Director of Research of the Graduate School of Integrative Medicine at Swinburne University, where he assisted in implementing post graduate courses for medical graduates in the areas of nutrition and environmental medicine and integrative medicine. He has served as a member of the Cancer Council's epidemiology group, has been an alternate director of the Victorian Public Health Research and Education Council and a member of its research committee. He was a member of the executive board of the Australian Research Centre for Complementary and Alternative Medicine. He was also an honorary affiliate with the Department of Medicine, Nursing and Health Sciences, Monash University.
Earlier appointments include Senior Research Associate with the University of Melbourne's Faculty of Medicine - Centre for Palliative Care at Caritas Christi Hospice and St Vincent's Hospital and a University of Melbourne Research Fellow with the Faculty of Medicine and the Department of Surgery at the Austin and Repatriation Medical Centre.
Professor Vitetta has research interests in nutrition, functional foods and immune function, as well as Mind Body Medicine. He was the first internationally funded Australian researcher investigating Chinese Herbal Medicines in a trial with HIV patients. He is frequently invited to speak at local and international conferences.
Naturopath & Herbalist
Michael is a PhD scholar at the University of Sydney, Sydney Medical School in the Discipline of Pharmacology and is affiliated with Medlab Clinical. He has a Master’s degree in Applied Science and has been practicing as a naturopath and herbalist for 30 years, specialising in cancer support utilising nutritional and herbal medicines and hyperthermia devices. Michael is researching chemoradiotherapy-induced mucositis, intestinal dysbiosis and the role of probiotics in preventing and or reducing chemotherapy/radiotherapy-induced diarrhoea in patients diagnosed with cancer.
Research and Development Scientist
Jiezhong Chen obtained a PhD in molecular medicine from the University of Sydney and a Master degree in Management Studies from the University of New South Wales. He has worked in various universities in Australia and USA, studying the mechanisms of various diseases including cancer, obesity, diabetes, cholestasis and osteoarthritis. His research has emphasized translational approaches for the prevention and treatment of these diseases. His outstanding research outcomes are evidenced by more than 100 scientific publications. In Medlab, he is working on the roles of gut microbiota in the pathogenesis of some common diseases such as obesity, diabetes, non-alcoholic fatty liver disease, cancer and depression, and the implications of probiotics as well as gut microbiota metabolites such as short chain fatty acids for ameliorating microbiota-associated diseases.